Latest Tax Credits News

Carnegie Clean Energy’s Spanish subsidiary has sold its 2025 Basque R&D tax deductions for €773,163, securing immediate funding to advance its ocean wave energy technology under the ACHIEVE Programme.

Australia and New Zealand Banking Group Limited (ANZ) has announced a quarterly distribution of AUD 1.2013 per security on its CAP NOTE AN3PK, payable in March 2026. The payment is 70% franked and subject to standard conditions and ANZ’s discretion.

Everest Metals Corporation has announced the issuance of $1.17 million in Junior Minerals Exploration Incentive tax credits to eligible shareholders following successful capital raisings in 2024-25. This move highlights the company’s ongoing commitment to exploration and shareholder value.

Renegade Exploration has secured an option to acquire the Rooster Hill Monazite Project in Wyoming, tapping into a historically promising rare earth element resource. The move expands Renegade’s US footprint amid rising demand for critical minerals.

Commonwealth Bank of Australia announces a fully franked dividend of AUD 1.1154 per security on its PERLS XIII hybrid notes, scheduled for payment in March 2026.

Bendigo and Adelaide Bank has announced a fully franked quarterly dividend of AUD 1.311 per security on its Capital Note BENPH, payable in March 2026. This distribution reflects a steady income stream aligned with the terms set out in the 2020 prospectus.

Bank of Queensland Limited has announced a fully franked quarterly distribution of AUD 1.2412 per Capital Note 3 security, payable in March 2026. The distribution reflects a 4.9784% annualised rate based on the BBSW plus a margin.

Goodman Group has announced an estimated ordinary dividend of AUD 0.15 per security for the six months ending December 2025, with payment scheduled for February 2026. The dividend is unfranked, and final details will be confirmed in February.

Charter Hall Retail REIT has announced a quarterly unfranked dividend of AUD 0.064 per unit, payable in February 2026, maintaining steady income for investors amid a stable retail property market.

Macquarie Group Limited has announced an ordinary dividend of AUD 1.6883 per security for its perpetual capital notes, payable in March 2026. The distribution features a partially franked yield reflecting current market interest rates.

ALS Limited has announced a partially franked interim dividend of 19.4 cents per share, payable mid-December, alongside a dividend reinvestment plan priced at $21.97 per share with no discount.

Chimeric Therapeutics has won FDA Orphan Drug Designation for its CHM CDH17 CAR-T therapy targeting gastric cancer, advancing its clinical development with regulatory incentives and potential market exclusivity.